Eton Pharmaceuticals, Inc. Ratios

Ratios Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin 52.76%-633.33%87.05%67.38%66.56%60.01%
EBT Margin -1,910.32%-71,717.95%-8.95%-42.45%-2.18%-9.76%
EBIT Margin -1,939.62%-69,515.38%-6.85%-38.87%-3.77%-6.66%
EBITDA Margin -1,939.62%-69,515.38%-6.85%-38.87%-3.77%-6.66%
Operating Margin -1,939.62%-69,515.38%-6.85%-38.87%-3.77%-6.66%
Net Margin -1,910.32%-71,717.95%-8.95%-42.45%-2.96%-9.80%
FCF Margin -1,993.95%-57,425.64%-21.67%22.51%21.54%2.42%
Efficiency
Inventory Average 0.81M0.90M0.55M0.73M8.07M
Assets Average 21.70M26.89M26.25M28.39M53.93M
Equity Average 13.11M16.65M15.35M14.28M19.95M
Invested Capital 15.09M22.20M22.89M18.46M20.86M54.24M
Asset Utilization Ratio 0.000.810.811.110.72
Leverage & Solvency
Debt to Equity 0.020.080.080.351.22
Debt Ratio 0.010.050.040.170.39
Equity Ratio 0.620.600.640.520.490.32
Valuation
Enterprise Value 107.76M116.15M175.56M91.15M55.03M91.00M329.20M
Market Capitalization 107.76M128.21M196.86M105.56M71.34M112.38M344.14M
Return Ratios
Return on Sales -19.10%-717.18%-0.09%-0.42%-0.03%-0.10%
Return on Capital Employed -1.51%-0.07%-0.42%-0.10%-0.08%
Return on Assets -1.29%-0.07%-0.34%-0.03%-0.07%
Return on Equity -2.13%-0.12%-0.59%-0.07%-0.19%